Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, April 30, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study
Life Sciences Times
-
April 30, 2026
Pharma
Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study
Life Sciences Times
-
April 30, 2026
Pharma
Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment
Life Sciences Times
-
April 30, 2026
Pharma
Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal
Life Sciences Times
-
April 29, 2026
Pharma
FDA Accepts New Drug Application for Zipalertinib in EGFR-Mutated Lung Cancer
Life Sciences Times
-
April 28, 2026
Pharma
Zai Lab Announces China Approval of COBENFY as First-in-Class Schizophrenia Treatment
Life Sciences Times
-
December 23, 2025
0
Pharma
Savara Resubmits FDA Application for MOLBREEVI in Autoimmune Pulmonary Alveolar Proteinosis
Life Sciences Times
-
December 22, 2025
0
Pharma
KalVista Wins Japanese Approval for EKTERLY, First Oral On-Demand Treatment for Hereditary Angioedema
Life Sciences Times
-
December 22, 2025
0
Pharma
ENHERTU Granted FDA Breakthrough Therapy Designation as Post-Neoadjuvant Treatment for HER2-Positive Early Breast Cancer
Life Sciences Times
-
December 22, 2025
0
Pharma
Takeda Phase 3 Data Show Once-Daily Zasocitinib Delivers High Rates of Skin Clearance in Plaque Psoriasis
Life Sciences Times
-
December 19, 2025
0
Pharma
Cosette Pharmaceuticals Launches First Generic Version of CIPRO HC Following FDA Approval
Life Sciences Times
-
December 16, 2025
0
Pharma
Acadia Pharmaceuticals Wins FDA Approval for DAYBUE STIX Powder Formulation for Rett Syndrome
Life Sciences Times
-
December 12, 2025
0
Pharma
ImmunityBio Wins EMA Recommendation for Conditional Approval of ANKTIVA With BCG for Bladder Cancer
Life Sciences Times
-
December 12, 2025
0
Pharma
Innoviva Specialty Therapeutics Reports Lancet Publication of Positive Phase 3 Data for Zoliflodacin in Gonorrhea
Life Sciences Times
-
December 12, 2025
0
Pharma
Prilenia and Ferrer gain FDA approval to launch Phase 3 ALS study of pridopidine
Life Sciences Times
-
December 11, 2025
0
Pharma
FDA Accepts Tris Pharma’s NDA for Once-Nightly, Low-Sodium Oxybate for Narcolepsy and Idiopathic Hypersomnia
Life Sciences Times
-
December 9, 2025
0
Pharma
Delphia Therapeutics Adds Cancer Expert Steve Kelsey, M.D., to Board of Directors
Life Sciences Times
-
December 9, 2025
0
1
...
6
7
8
...
91
Page 7 of 91
Most Read
Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study
April 30, 2026
Johnson & Johnson Names Ryan Koors Vice President of Investor Relations
April 30, 2026
Moleculent Raises $20 Million to Expand Functional Profiling Platform
April 30, 2026
Komodo Health Names Paul Thomas Chief Financial Officer
April 30, 2026